PIM
VRTX icon

Partner Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Partner Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$95K Buy
+434
New +$87.8K 0.68% 36
2016
Q3 		– Sell
-3,425
Closed -$295K – 105
2016
Q2 		$295K Buy
+3,425
New +$296K 0.48% 61

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Partner Investment Management's VRTX Position: Q4 2019 in Review

Partner Investment Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2019: 434 shares worth $95K. The stake represents 0.68% of the portfolio and ranks #36 among its holdings. This is a return to the name: Partner Investment Management previously reported a position in VRTX as recently as Q2 2016.

Partner Investment Management first reported a position in VRTX in Q2 2016 and has held it in 2 quarters since. The position peaked at $295K in Q2 2016. 814 funds tracked by Wall St. Rank hold VRTX as of Q4 2019.

  • Partner Investment Management held 434 shares of Vertex Pharmaceuticals worth $95K as of Q4 2019.
  • Vertex Pharmaceuticals was a new Partner Investment Management position in Q4 2019.
  • Vertex Pharmaceuticals made up 0.68% of Partner Investment Management's portfolio in Q4 2019, its #36 holding.
  • Partner Investment Management first reported a position in Vertex Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Partner Investment Management's Vertex Pharmaceuticals position peaked at $295K in Q2 2016.
  • 814 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.